Evidence map›Paper›PMID 19884464›Full record

ArticleCirculation2009

History and current impact of cardiac magnetic resonance imaging on the management of iron overload.

John C Wood

Abstract readEditorialComment
In one paragraph

Article in Circulation, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Herceptin induces ferroptosis and mitochondrial dysfunction in H9c2 cells.International journal of molecular medicine · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Management of cardiac hemochromatosis.Archives of medical science : AMS · 2018
    Article
  11. Article
  12. Article
  13. Myelodysplastic Syndromes and Iron Chelation Therapy.Mediterranean journal of hematology and infectious diseases · 2017
    Review
  14. Review
  15. Review
  16. Article
  17. Use of magnetic resonance imaging to monitor iron overload.Hematology/oncology clinics of North America · 2014
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

John C Wood

Funding

ZOPOLRESTAT IN NORMOTENSIVE, TYPE 1 DIA WITH INCIPIENT NEPHROPATHYM01RR000043 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZAIA, JOHN A · 1985 to 2010
$76.4M
Cardiac Function and Cardiac iron (T2*) in ThalassemiaR01HL075592 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI WOOD, JOHN C · 2004 to 2007
$1.6M
NCRR NIH HHS M01 RR000043NCRR NIH HHS RR00043-43NHLBI NIH HHS 1 RO1 HL075592-01NHLBI NIH HHS R01 HL075592PHS HHS U27/CCU922106
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultArrhythmias, Cardiacbeta-ThalassemiaFemaleFerritinsFollow-Up StudiesHeart FailureHemosiderosisHumansIronLiverMagnetic Resonance ImagingMalePredictive Value of TestsRadiographyFerritinsIron

Identifiers

PMID19884464
PMCPMC2884388

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.